3MEB
Structure of cytoplasmic aspartate aminotransferase from giardia lamblia
Summary for 3MEB
| Entry DOI | 10.2210/pdb3meb/pdb |
| Descriptor | Aspartate aminotransferase, SULFATE ION, PYRIDOXAL-5'-PHOSPHATE, ... (5 entities in total) |
| Functional Keywords | aspartate aminotransferase, aminotransferase, pyridoxal phosphate, transferase, structural genomics, seattle structural genomics center for infectious disease, ssgcid |
| Biological source | Giardia lamblia |
| Total number of polymer chains | 2 |
| Total formula weight | 101692.11 |
| Authors | Seattle Structural Genomics Center for Infectious Disease (SSGCID) (deposition date: 2010-03-31, release date: 2010-04-21, Last modification date: 2023-09-06) |
| Primary citation | Abendroth, J.,Choi, R.,Wall, A.,Clifton, M.C.,Lukacs, C.M.,Staker, B.L.,Van Voorhis, W.,Myler, P.,Lorimer, D.D.,Edwards, T.E. Structures of aspartate aminotransferases from Trypanosoma brucei, Leishmania major and Giardia lamblia. Acta Crystallogr F Struct Biol Commun, 71:566-571, 2015 Cited by PubMed Abstract: The structures of three aspartate aminotransferases (AATs) from eukaryotic pathogens were solved within the Seattle Structural Genomics Center for Infectious Disease (SSGCID). Both the open and closed conformations of AAT were observed. Pyridoxal phosphate was bound to the active site via a Schiff base to a conserved lysine. An active-site mutant showed that Trypanosoma brucei AAT still binds pyridoxal phosphate even in the absence of the tethering lysine. The structures highlight the challenges for the structure-based design of inhibitors targeting the active site, while showing options for inhibitor design targeting the N-terminal arm. PubMed: 25945710DOI: 10.1107/S2053230X15001831 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report






